BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36231768)

  • 1. Pharmacoepidemiological Research on N-Nitrosodimethylamine-Contaminated Ranitidine Use and Long-Term Cancer Risk: A Population-Based Longitudinal Cohort Study.
    Wang CH; Chen II; Chen CH; Tseng YT
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Cancer Following the Use of N-Nitrosodimethylamine (NDMA) Contaminated Ranitidine Products: A Nationwide Cohort Study in South Korea.
    Yoon HJ; Kim JH; Seo GH; Park H
    J Clin Med; 2021 Jan; 10(1):. PubMed ID: 33466237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between ranitidine use with potential NDMA impurities and risk of cancer in Korea.
    Joung KI; Hwang JE; Oh IS; Cho SI; Shin JY
    Sci Rep; 2022 Dec; 12(1):22396. PubMed ID: 36575247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Nitrosodimethylamine-Contaminated Valsartan and the Risk of Cancer—A Longitudinal Cohort Study Based on German Health Insurance Data.
    Gomm W; Röthlein C; Schüssel K; Brückner G; Schröder H; Heß S; Frötschl R; Broich K; Haenisch B
    Dtsch Arztebl Int; 2021 May; 118(21):357-362. PubMed ID: 34247699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association between chronic use of ranitidine, compared with omeprazole or famotidine, and gastrointestinal malignancies.
    Kim YD; Wang J; Shibli F; Poels KE; Ganocy SJ; Fass R
    Aliment Pharmacol Ther; 2021 Sep; 54(5):606-615. PubMed ID: 34251045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ranitidine Use and Gastric Cancer Among Persons with Helicobacter pylori.
    Kumar S; Goldberg DS; Kaplan DE
    Dig Dis Sci; 2022 May; 67(5):1822-1830. PubMed ID: 33856609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranitidine Use and Incident Cancer in a Multinational Cohort.
    You SC; Seo SI; Falconer T; Yanover C; Duarte-Salles T; Seager S; Posada JD; Shah NH; Nguyen PA; Kim Y; Hsu JC; Van Zandt M; Hsu MH; Lee HL; Ko H; Shin WG; Pratt N; Park RW; Reich CG; Suchard MA; Hripcsak G; Park CH; Prieto-Alhambra D
    JAMA Netw Open; 2023 Sep; 6(9):e2333495. PubMed ID: 37725377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of N-nitrosodimethylamine (NDMA) contaminated valsartan products and risk of cancer: Danish nationwide cohort study.
    Pottegård A; Kristensen KB; Ernst MT; Johansen NB; Quartarolo P; Hallas J
    BMJ; 2018 Sep; 362():k3851. PubMed ID: 30209057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Ranitidine Intake on the Risk of Gastric Cancer Development.
    Kim S; Lee S; Hong J; Ko I; Kim JY; Kim DK
    Healthcare (Basel); 2021 Aug; 9(8):. PubMed ID: 34442208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding and Preventing (
    White CM
    Ann Pharmacother; 2020 Jun; 54(6):611-614. PubMed ID: 31771343
    [No Abstract]   [Full Text] [Related]  

  • 11. Ranitidine Use and Risk of Upper Gastrointestinal Cancers.
    Adami HO; Trolle Andersen I; Heide-Jørgensen U; Chang ET; Nørgaard M; Sørensen HT
    Cancer Epidemiol Biomarkers Prev; 2021 Dec; 30(12):2302-2308. PubMed ID: 34620629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histamine H2 receptor antagonist exposure was related to decreased all-cause mortality in critical ill patients with heart failure: a cohort study.
    Huang YH; Cai WK; Yin SJ; Wang P; Li ZR; Yang Q; Zhou T; Meng R; Yang M; Guo Y; He GH
    Eur J Prev Cardiol; 2022 Oct; 29(14):1854-1865. PubMed ID: 35707983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of N-nitrosodimethylamine formation from the ozonation of ranitidine.
    Lv J; Wang L; Li Y
    J Environ Sci (China); 2017 Aug; 58():116-126. PubMed ID: 28774600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-nitrosodimethylamine (NDMA) contamination of ranitidine products: A review of recent findings.
    Aldawsari FS; Alshehry YM; Alghamdi TS
    J Food Drug Anal; 2021 Mar; 29(1):39-45. PubMed ID: 35696227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranitidine and Risk of Bladder and Kidney Cancer: A Population-Based Cohort Study.
    Nørgaard M; Andersen IT; Heide-Jørgensen U; Erichsen R; Rees JR; Karagas MR; Sørensen HT
    Cancer Epidemiol Biomarkers Prev; 2022 Jan; 31(1):45-50. PubMed ID: 34649959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylaxis against acid aspiration in regional anesthesia for elective cesarean section: a comparison between oral single-dose ranitidine, famotidine and omeprazole assessed with fiberoptic gastric aspiration.
    Lin CJ; Huang CL; Hsu HW; Chen TL
    Acta Anaesthesiol Sin; 1996 Dec; 34(4):179-84. PubMed ID: 9084544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Association between Ranitidine Use and Gastrointestinal Cancers.
    McGwin G
    Cancers (Basel); 2020 Dec; 13(1):. PubMed ID: 33374592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A controlled study of 20 mg famotidine nocte vs. 150 mg ranitidine nocte for the prevention of duodenal ulcer relapse.
    Bianchi Porro G; Lazzaroni M; Barbara L; Corinaldesi R; Blasi A; Mangiameli A; Capurso L; Koch M; Cheli R; Bovero E
    Aliment Pharmacol Ther; 1991 Apr; 5(2):181-9. PubMed ID: 1888818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HS-SPME-GC-MS as an alternative method for NDMA analysis in ranitidine products.
    Alshehri YM; Alghamdi TS; Aldawsari FS
    J Pharm Biomed Anal; 2020 Nov; 191():113582. PubMed ID: 32889348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ranitidine on quality of gastric ulcer healing compared with famotidine: a randomized, controlled, multicenter trial.
    Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Uchida T; Fujiwara Y; Arakawa T
    Int J Clin Pharmacol Res; 2005; 25(4):187-94. PubMed ID: 16402635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.